Learn
Clear, concise, research-backed information on psychedelics. We cover the latest neuroscience, practical safety practices, evolving legal landscape, and clinical therapeutic developments (2024–2026 data). Start here for responsible exploration.
Science
How psychedelics act on the brain: 5-HT2A, neuroplasticity, DMN, and 2026 research updates.
Safety & Harm Reduction
Set & setting, substance testing, trip support, integration, and current best practices.
Legal Landscape (2026)
Federal Schedule I, state therapeutic programs in OR/CO/NM, decriminalization, and policy shifts.
Therapeutic Research
Psilocybin, MDMA, LSD in Phase 3 trials, 2026 FDA fast-track updates, and real-world outcomes.
Safety Checklist
Build and print a personalized, evidence-based checklist for preparation, the session, and integration.
Dosage Calculator
Fixed-dose recommendations (preferred) and weight-based options based on clinical trial data for dried Psilocybe cubensis.
All content is informational only. Laws and science evolve quickly—cross-reference primary sources.
Disclaimer: Cybinly provides this educational content for informational and harm-reduction purposes only. It is not medical, legal, or therapeutic advice. Psychedelic substances remain Schedule I under U.S. federal law and are illegal in most jurisdictions. Laws are rapidly evolving—always verify current regulations with official sources. Consult qualified healthcare professionals before considering any substance. If you or someone you know is in crisis, contact the Fireside Project at (623) 473-7433 or firesideproject.org.
Content reflects research and policy as of mid-2026. Last major update: 2026.